Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2025-524327-53-00Phase 4Authorised
Phase 4, randomised trial of progesterone in infertility (2 arms), sponsored by Central Denmark Region. Primary endpoint: Clinical pregnancy rate. Planned start Aug 2026; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2025-524327-53-00.